WebJan 7, 2024 · In the CRYSTAL AF trial, the median time for atrial fibrillation (AF) detection via implanted cardiac monitor (ICM) was 8.4 months. A meta-analysis of ICM use in patients monitored for AF reported detection rates of 5% for <6 months, 26% for 12-24 months, and 34% for >24 months of monitoring. WebMar 31, 2024 · We modeled the economic impact of anticoagulating ESUS patients without documented AF across multiple geographies. Methods: CRYSTAL-AF trial data were used to assess ischaemic stroke event rates in ESUS patients confirmed AF …
Cryptogenic Stroke and Underlying Atrial …
WebMay 26, 2016 · The long-established Trial of Org 10172 in Acute Stroke Treatment (TOAST) diagnostic algorithm 17,18 is beginning to be superseded by the newer ASCOD (atherosclerosis, small-vessel disease,... WebFeb 13, 2015 · A total of 1,247 patients suffering from cryptogenic stroke across the U.S. were examined. Evidently post 182 days of monitoring, the AF detection rate in the real world study was 12.2%, 37%... portee french
Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A ...
WebFeb 9, 2024 · STROKE AF at 3 Years: High AF Rate After Atherosclerotic Stroke Sue Hughes February 09, 2024 In the STROKE AF study, among patients who had had a stroke that was presumably caused by... WebBackground: Since the CRYSTAL-AF trial, implantation and usage of implantable loop recorder (ICM) after cryptogenic stroke (CS) for detection of atrial fibrillation (AF) has increased. However, it is unclear which CS patients would most benefit from long term ICM monitoring. This study aims to determine the risk factors in patients that would confer … WebFeb 15, 2014 · CRYSTAL-AF: Monitor Detects AF in Cryptogenic Stroke Sue Hughes February 15, 2014 An implanted cardiac monitor was much more effective at picking up … portee plancher rector